nodes	percent_of_prediction	percent_of_DWPC	metapath
Ajmaline—ORM1—Abiraterone—prostate cancer	0.62	0.668	CbGbCtD
Ajmaline—CYP2D6—Bicalutamide—prostate cancer	0.155	0.167	CbGbCtD
Ajmaline—CYP2D6—Abiraterone—prostate cancer	0.129	0.139	CbGbCtD
Ajmaline—CYP2D6—Doxorubicin—prostate cancer	0.0238	0.0256	CbGbCtD
Ajmaline—SCN5A—Axon guidance—PRNP—prostate cancer	0.000237	0.00325	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000236	0.00324	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	0.000235	0.00322	CbGpPWpGaD
Ajmaline—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	0.000231	0.00317	CbGpPWpGaD
Ajmaline—SCN5A—L1CAM interactions—MAP2K1—prostate cancer	0.000229	0.00314	CbGpPWpGaD
Ajmaline—SCN5A—Cardiac Progenitor Differentiation—TGFB1—prostate cancer	0.000228	0.00313	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	0.000224	0.00306	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—EZR—prostate cancer	0.000223	0.00306	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000218	0.00299	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—EPHX1—prostate cancer	0.000211	0.00289	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	0.000208	0.00286	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	0.000206	0.00282	CbGpPWpGaD
Ajmaline—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	0.000206	0.00282	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—NRP1—prostate cancer	0.000204	0.0028	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—HNF1B—prostate cancer	0.000204	0.0028	CbGpPWpGaD
Ajmaline—CYP2D6—Melatonin metabolism and effects—GSK3B—prostate cancer	0.000201	0.00276	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—prostate cancer	0.000201	0.00275	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000199	0.00273	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	0.000199	0.00272	CbGpPWpGaD
Ajmaline—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—prostate cancer	0.000198	0.00272	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	0.000197	0.00271	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP7B1—prostate cancer	0.000195	0.00268	CbGpPWpGaD
Ajmaline—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.000195	0.00267	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP7B1—prostate cancer	0.000193	0.00264	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—SULT1E1—prostate cancer	0.00019	0.00261	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	0.00019	0.00261	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	0.000188	0.00258	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—SULT1E1—prostate cancer	0.000188	0.00257	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—HSP90AB1—prostate cancer	0.000186	0.00255	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	0.000186	0.00255	CbGpPWpGaD
Ajmaline—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	0.000183	0.00251	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	0.000181	0.00248	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	0.000179	0.00246	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—PRNP—prostate cancer	0.000169	0.00232	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	0.000169	0.00231	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP3A5—prostate cancer	0.000168	0.0023	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—MED12—prostate cancer	0.000167	0.00228	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP3A5—prostate cancer	0.000165	0.00227	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—prostate cancer	0.000163	0.00223	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000162	0.00223	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTA3—prostate cancer	0.000162	0.00222	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	0.00016	0.00219	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—GSTA3—prostate cancer	0.00016	0.00219	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—NCOA3—prostate cancer	0.000159	0.00218	CbGpPWpGaD
Ajmaline—SCN5A—L1CAM interactions—SRC—prostate cancer	0.000159	0.00218	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—PRKCQ—prostate cancer	0.000158	0.00217	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	0.000153	0.00209	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	0.00015	0.00206	CbGpPWpGaD
Ajmaline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	0.00015	0.00205	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—TBXAS1—prostate cancer	0.000148	0.00203	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTA4—prostate cancer	0.000148	0.00203	CbGpPWpGaD
Ajmaline—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.000148	0.00202	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—GSTA4—prostate cancer	0.000146	0.002	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	0.000145	0.00199	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—VAV3—prostate cancer	0.000145	0.00199	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTA2—prostate cancer	0.000144	0.00198	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—SULT1A1—prostate cancer	0.000142	0.00195	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—SULT1A1—prostate cancer	0.000141	0.00193	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTA1—prostate cancer	0.000139	0.00191	CbGpPWpGaD
Ajmaline—SCN5A—L1CAM interactions—EGFR—prostate cancer	0.000139	0.00191	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTO1—prostate cancer	0.000138	0.00189	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—NAT2—prostate cancer	0.000138	0.00189	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—GSTO1—prostate cancer	0.000136	0.00186	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—NAT2—prostate cancer	0.000136	0.00186	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—NCOA2—prostate cancer	0.000133	0.00182	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP2C18—prostate cancer	0.000132	0.00181	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP2C18—prostate cancer	0.00013	0.00178	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000129	0.00177	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—ITGB3—prostate cancer	0.000125	0.00171	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000123	0.00169	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—SULT2A1—prostate cancer	0.000123	0.00168	CbGpPWpGaD
Ajmaline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000121	0.00166	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—SULT2A1—prostate cancer	0.000121	0.00166	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000119	0.00163	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—GPX3—prostate cancer	0.000115	0.00158	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—PRKCQ—prostate cancer	0.000113	0.00155	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—NCOA1—prostate cancer	0.000112	0.00154	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000111	0.00152	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—HPGDS—prostate cancer	0.00011	0.00151	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP2C19—prostate cancer	0.000109	0.0015	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP2C19—prostate cancer	0.000108	0.00148	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—FGF10—prostate cancer	0.000107	0.00147	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTT1—prostate cancer	0.000107	0.00146	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—RXRA—prostate cancer	0.000107	0.00146	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—KDR—prostate cancer	0.000106	0.00145	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP2A6—prostate cancer	0.000105	0.00145	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000105	0.00144	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—VAV3—prostate cancer	0.000104	0.00142	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—AKR1C3—prostate cancer	0.000101	0.00139	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP17A1—prostate cancer	0.000101	0.00138	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP17A1—prostate cancer	9.96e-05	0.00137	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—NCOA2—prostate cancer	9.62e-05	0.00132	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—GSK3B—prostate cancer	9.37e-05	0.00128	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—LPL—prostate cancer	9.21e-05	0.00126	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP2E1—prostate cancer	8.97e-05	0.00123	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—ITGB3—prostate cancer	8.9e-05	0.00122	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP2E1—prostate cancer	8.84e-05	0.00121	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—MMP2—prostate cancer	8.65e-05	0.00119	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP3A4—prostate cancer	8.65e-05	0.00119	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—MAP2K1—prostate cancer	8.64e-05	0.00118	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP3A4—prostate cancer	8.53e-05	0.00117	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP1B1—prostate cancer	8.5e-05	0.00117	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP1B1—prostate cancer	8.38e-05	0.00115	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GGT1—prostate cancer	8.23e-05	0.00113	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—PPARA—prostate cancer	8.14e-05	0.00112	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—NCOA1—prostate cancer	8.11e-05	0.00111	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP19A1—prostate cancer	7.99e-05	0.0011	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP19A1—prostate cancer	7.88e-05	0.00108	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—JAK2—prostate cancer	7.88e-05	0.00108	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—LEP—prostate cancer	7.72e-05	0.00106	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—RXRA—prostate cancer	7.71e-05	0.00106	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—ERBB2—prostate cancer	7.58e-05	0.00104	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—KDR—prostate cancer	7.56e-05	0.00104	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—COMT—prostate cancer	7.43e-05	0.00102	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTP1—prostate cancer	7.4e-05	0.00101	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—COMT—prostate cancer	7.33e-05	0.001	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—GSTP1—prostate cancer	7.29e-05	0.001	CbGpPWpGaD
Ajmaline—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	7.25e-05	0.000994	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—GSTM1—prostate cancer	6.8e-05	0.000932	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—GSTM1—prostate cancer	6.7e-05	0.000919	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—GSK3B—prostate cancer	6.69e-05	0.000917	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—INS—prostate cancer	6.6e-05	0.000904	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—MMP9—prostate cancer	6.5e-05	0.000892	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—CREBBP—prostate cancer	6.46e-05	0.000886	CbGpPWpGaD
Ajmaline—CYP2D6—Biological oxidations—CYP1A1—prostate cancer	6.44e-05	0.000883	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—HAO1—prostate cancer	6.36e-05	0.000872	CbGpPWpGaD
Ajmaline—CYP2D6—Metapathway biotransformation—CYP1A1—prostate cancer	6.35e-05	0.000871	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—MMP2—prostate cancer	6.17e-05	0.000847	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—MAP2K1—prostate cancer	6.17e-05	0.000846	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—SRC—prostate cancer	6e-05	0.000822	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—FGF2—prostate cancer	5.86e-05	0.000804	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—VEGFA—prostate cancer	5.84e-05	0.000801	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—JAK2—prostate cancer	5.62e-05	0.000771	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—ERBB2—prostate cancer	5.41e-05	0.000742	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—EGFR—prostate cancer	5.26e-05	0.000721	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CSAD—prostate cancer	5.18e-05	0.000711	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GRHL1—prostate cancer	5.18e-05	0.000711	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PSAT1—prostate cancer	5.18e-05	0.000711	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CBR1—prostate cancer	5.18e-05	0.000711	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—ADI1—prostate cancer	5.18e-05	0.000711	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—TST—prostate cancer	5.18e-05	0.000711	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—KRAS—prostate cancer	4.96e-05	0.000681	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CKMT2—prostate cancer	4.82e-05	0.000661	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—UGT2B15—prostate cancer	4.82e-05	0.000661	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—UGT2B17—prostate cancer	4.82e-05	0.000661	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GRHPR—prostate cancer	4.82e-05	0.000661	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—CTNNB1—prostate cancer	4.73e-05	0.000649	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—MMP9—prostate cancer	4.64e-05	0.000636	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—MBTPS1—prostate cancer	4.53e-05	0.000621	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SULT2B1—prostate cancer	4.53e-05	0.000621	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PGAM2—prostate cancer	4.53e-05	0.000621	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NAGLU—prostate cancer	4.53e-05	0.000621	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—RFK—prostate cancer	4.53e-05	0.000621	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—AOX1—prostate cancer	4.53e-05	0.000621	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTM3—prostate cancer	4.53e-05	0.000621	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—EP300—prostate cancer	4.4e-05	0.000603	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—AMACR—prostate cancer	4.3e-05	0.000589	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP3A43—prostate cancer	4.3e-05	0.000589	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—DEGS1—prostate cancer	4.3e-05	0.000589	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SRD5A2—prostate cancer	4.3e-05	0.000589	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NAT1—prostate cancer	4.3e-05	0.000589	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—SRC—prostate cancer	4.28e-05	0.000587	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—VEGFA—prostate cancer	4.17e-05	0.000571	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—STAT3—prostate cancer	4.13e-05	0.000566	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—HSD17B1—prostate cancer	4.1e-05	0.000562	CbGpPWpGaD
Ajmaline—SCN5A—Axon guidance—IL6—prostate cancer	4.04e-05	0.000554	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—TGFB1—prostate cancer	3.82e-05	0.000524	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—EGFR—prostate cancer	3.75e-05	0.000514	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—B4GALT4—prostate cancer	3.65e-05	0.000501	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—HPGD—prostate cancer	3.65e-05	0.000501	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—KRAS—prostate cancer	3.54e-05	0.000486	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—TNFRSF21—prostate cancer	3.43e-05	0.000471	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP7B1—prostate cancer	3.34e-05	0.000458	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—MTAP—prostate cancer	3.34e-05	0.000458	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SULT1E1—prostate cancer	3.26e-05	0.000446	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SRD5A1—prostate cancer	3.26e-05	0.000446	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—ACSL4—prostate cancer	3.11e-05	0.000426	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—HSD17B3—prostate cancer	3.11e-05	0.000426	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PHGDH—prostate cancer	2.98e-05	0.000408	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—ARG2—prostate cancer	2.98e-05	0.000408	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—UMPS—prostate cancer	2.98e-05	0.000408	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—LDHB—prostate cancer	2.92e-05	0.0004	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—IL6—prostate cancer	2.88e-05	0.000395	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP3A5—prostate cancer	2.87e-05	0.000393	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PDHA1—prostate cancer	2.77e-05	0.00038	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTA3—prostate cancer	2.77e-05	0.00038	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—UCP3—prostate cancer	2.77e-05	0.00038	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—TCN2—prostate cancer	2.77e-05	0.00038	CbGpPWpGaD
Ajmaline—SCN5A—Developmental Biology—AKT1—prostate cancer	2.66e-05	0.000365	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—HSD3B1—prostate cancer	2.64e-05	0.000362	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SLC22A3—prostate cancer	2.64e-05	0.000362	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTA4—prostate cancer	2.53e-05	0.000347	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—TBXAS1—prostate cancer	2.53e-05	0.000347	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTA2—prostate cancer	2.47e-05	0.000338	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—ABCG5—prostate cancer	2.44e-05	0.000334	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SULT1A1—prostate cancer	2.44e-05	0.000334	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTA1—prostate cancer	2.38e-05	0.000326	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTO1—prostate cancer	2.35e-05	0.000323	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—HSD3B2—prostate cancer	2.35e-05	0.000323	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NAT2—prostate cancer	2.35e-05	0.000323	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PLCB2—prostate cancer	2.26e-05	0.000309	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP2C18—prostate cancer	2.26e-05	0.000309	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—LRP2—prostate cancer	2.26e-05	0.000309	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—P4HB—prostate cancer	2.21e-05	0.000303	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SLC22A1—prostate cancer	2.15e-05	0.000295	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SULT2A1—prostate cancer	2.1e-05	0.000288	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—MED12—prostate cancer	2.06e-05	0.000283	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GNG5—prostate cancer	2.05e-05	0.000281	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NCOA3—prostate cancer	1.97e-05	0.00027	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—HPGDS—prostate cancer	1.88e-05	0.000258	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP2C19—prostate cancer	1.87e-05	0.000256	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—ACHE—prostate cancer	1.82e-05	0.00025	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTT1—prostate cancer	1.82e-05	0.00025	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.8e-05	0.000247	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.75e-05	0.000241	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PRKACB—prostate cancer	1.75e-05	0.000239	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.73e-05	0.000237	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NCOA2—prostate cancer	1.65e-05	0.000226	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.57e-05	0.000215	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.53e-05	0.00021	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NQO1—prostate cancer	1.52e-05	0.000208	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—TH—prostate cancer	1.49e-05	0.000205	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.48e-05	0.000203	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.45e-05	0.000199	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GGT1—prostate cancer	1.41e-05	0.000193	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NCOA1—prostate cancer	1.39e-05	0.00019	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.37e-05	0.000187	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—RXRA—prostate cancer	1.32e-05	0.000181	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—COMT—prostate cancer	1.27e-05	0.000174	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTP1—prostate cancer	1.26e-05	0.000173	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—ITPR1—prostate cancer	1.24e-05	0.000171	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—TYMS—prostate cancer	1.18e-05	0.000161	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—GSTM1—prostate cancer	1.16e-05	0.000159	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—LPL—prostate cancer	1.14e-05	0.000156	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.1e-05	0.000151	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—ERCC2—prostate cancer	1.09e-05	0.00015	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—MTHFR—prostate cancer	1.03e-05	0.000141	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PPARA—prostate cancer	1.01e-05	0.000138	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CAV1—prostate cancer	9.47e-06	0.00013	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PIK3CG—prostate cancer	8.63e-06	0.000118	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—INS—prostate cancer	8.17e-06	0.000112	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—CREBBP—prostate cancer	8e-06	0.00011	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PIK3CD—prostate cancer	7.59e-06	0.000104	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—NOS3—prostate cancer	7.16e-06	9.82e-05	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PIK3CB—prostate cancer	6.61e-06	9.07e-05	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PTGS2—prostate cancer	6.55e-06	8.98e-05	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PTEN—prostate cancer	5.71e-06	7.84e-05	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—EP300—prostate cancer	5.45e-06	7.47e-05	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.03e-06	5.53e-05	CbGpPWpGaD
Ajmaline—CYP2D6—Metabolism—AKT1—prostate cancer	3.29e-06	4.52e-05	CbGpPWpGaD
